Shattuck Labs, Inc. (STTK)
NASDAQ · Manufacturing · Pharmaceutical preparations
STTK price, last 12 months
Key stats
- Previous close
- $6.31
- Open
- $6.33
- Day range
- $6.05 – $6.39
- 52-week range
- $1.70 – $8.33
- Volume
- 695.3K
- Avg volume (20 days)
- 1.2M
- Market cap
- $609.2M
Performance
Technicals and fundamentals
About Shattuck Labs, Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $609.2M